Related by context. Frequent words. (Click for all words.) 69 liposomal formulation 68 multi kinase inhibitor 68 HCV protease 68 Panzem R 67 Irinotecan 67 Amrubicin 67 Vandetanib 67 humanized anti 67 CYC# 67 Pivotal Phase 66 luteinizing hormone releasing 66 sphingosine 1 66 FGFR 66 humanized monoclonal antibody 66 drug conjugate 66 CD# antibody [001] 66 Metastatic Melanoma 66 CA4P 65 induces apoptosis 65 Pivotal Phase III 65 DAVANAT 65 Nexavar ® 65 APOPTONE 65 BZL# 65 HGS ETR1 65 GRN#L 65 PEG SN# 65 Azedra 64 partial agonist 64 SGLT2 64 potent inhibitor 64 multiple myeloma MM 64 registrational trial 64 IMC A# 64 Clevudine 64 factor G CSF 64 orally bioavailable 64 anticancer compound 64 OXi# 64 Aurora kinase 64 Epratuzumab 64 Voreloxin 64 ganetespib 64 Initiates Phase 64 anti CD# monoclonal 64 phase IIb clinical 63 Drug Candidate 63 hypoxia inducible factor 63 Phase III Clinical Trial 63 angiogenesis inhibitor 63 EpCAM 63 selective inhibitor 63 pertuzumab 63 mTOR inhibitor 63 AVE# 63 tyrosine kinase inhibitor 63 Natalizumab 63 HER2 positive metastatic breast 63 vorinostat 63 metastatic castration resistant 63 EndoTAG TM -1 63 Vascular Endothelial Growth 63 humanized antibody 63 metastatic hormone refractory 63 FLT3 63 Ofatumumab 63 C1 esterase inhibitor 63 Carfilzomib 63 Preclinical studies 63 seliciclib 63 Pirfenidone 63 Bavituximab 63 Clinical Trial Results 63 relapsed multiple myeloma 63 EZN 63 Onalta 63 R sorafenib tablets 63 anticancer agent 62 Bortezomib 62 CCX# 62 leukemia CLL 62 N methyl 62 adecatumumab 62 Panitumumab 62 thymalfasin 62 Presents Positive 62 Dasatinib 62 gastrin 62 Lenalidomide 62 Sym# 62 Perifosine 62 cutaneous T cell 62 BAL# [001] 62 Preclinical Data 62 FDA Accepts 62 EGF receptor 62 hematological cancers 62 MKC# 62 mRCC 62 androgen independent 62 PXD#